Repligen | RGEN - Ebitda





Ebitda تغيير تاريخ
Agilent USD 456M 84M 2025-12
Align Technology USD 229.14M 31.74M 2026-03
Bio Techne USD 116.71M 13.29M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Bruker USD 110M 101.6M 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Danaher USD 1.84B 81M 2026-06
Dentsply International USD 129M 6M 2026-03
General Electric Aerospace USD 3.06B 219M 2026-06
Henry Schein USD 289M 2M 2026-03
Illumina USD 330M 80M 2026-06
IQVIA Holdings USD 994M 62M 2026-06
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pfizer USD 5.99B 5.23B 2026-03
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 272.91M 24M 2026-03
Standard Biotools USD -8.01M 7.8M 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 243.6M 17.4M 2026-06